Effect of Prior Atorvastatin Treatment on the Frequency of Hospital Acquired Pneumonia and Evolution of Biomarkers in Patients with Acute Ischemic Stroke: A Multicenter Prospective Study

Table 5

Inflammatory markers at the day of VAP diagnosis and 10 days of treatment.

Variable	PG	NG	p
Day of VAP diagnosis
WBC (10^9/L)			0.531
PCT (ng/mL)			0.517
TNF-α (ng/L)			0.001
IL-6 (ng/mL)			0.010
10 days of treatment
WBC (10^9/L)			0.311
PCT (ng/mL)			0.459
TNF-α (ng/L)			0.001
IL-6 (ng/mL)			0.001